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1. Introduction 
Chronic kidney disease (CKD) is a progressive and irreversible loss of kidney function 
over a longer period of time. CKD slowly progresses to end-stage renal disease (ESRD), 
independently from the primary insult. ESRD is a life threatening condition, which 
requires renal replacement therapy in the forms of dialysis or kidney transplantation. The 
most common cause of CKD is diabetes mellitus (DM). The severity of symptoms and the 
rate of CKD progression are influenced by age, gender and numerous pieces of evidence 
support a role for genetic background in progression. Over the last decade significant 
progress has been made in the understanding of the molecular mechanisms behind CKD, 
however no specific treatment is available that would be able to arrest or reverse the 
progression. 
Glomerular injury is a key step in the development of many forms of CKD. The role of 
podocytes in glomerular injury is under intense investigation. Targeting toxins to the 
podocyte appears to be sufficient for inducing focal segmental glomerular sclerosis 
(FSGS) like lesions with albuminuria in rodents. For these reasons our workgroup 
performed several experiments to uncover new mechanisms behind the glomerular 
changes in CKD focusing on the role of podocytes. 
In the present thesis we focused on two aspects of CKD: 1. Glomerular injury as a result 
of diabetes mellitus, 2. The role of genetic background in the progression of doxorubicin 
toxicity induced CKD. 
 
1.1. Diabetic nephropathy: 
Diabetic nephropathy (DN) is a serious complication of diabetes mellitus occurring in 
approximately 20–30% of patients with diabetes mellitus, and it accounts for almost 50% 
of all ESRD. The earliest symptom of DN is microalbuminuria that progresses into 
nephrotic syndrome with high blood pressure and progressively impaired kidney function, 
which manifests as a decrease in glomerular filtration rate (GFR). 
Recent studies suggest that insulin signaling in podocytes is essential to maintain normal 
glomerular ultrafiltration. Deletion of the insulin receptor specifically from podocytes 
leads to albuminuria and histological changes resembling DN even under normoglycemic 
conditions. Treatment of cultured podocytes with insulin induces rapid remodeling of the 
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actin cytoskeleton. Proteins involved in actin organization can be therapeutic targets in the 
treatment of glomerular diseases, including DN. 
Ezrin is an important linker of membrane proteins to the underlying actin cytoskeleton 
with its interaction partner sodium-hydrogen exchange regulatory cofactor (NHERF2). 
Ezrin and NHERF2 are expressed in podocytes, where they connect the cell surface 
sialoprotein podocalyxin to actin. Also the N-terminal fragment of ezrin has been shown 
to bind to advanced glycation end products (AGEs) in the kidneys of diabetic rats. For 
these reasons ezrin may play an important role in podocyte injury in DN. 
 
1.2. The role of genetic background in CKD: 
The rate of progression of CKD varies between individuals with the same initial disease. 
Familial clustering and genome-wide association studies (GWAS) identified several gene 
mutations responsible for the development of CKD. These identified genes include: the 
Nephrosis 1 (NPHS1) gene which encodes nephrin, the alpha-actinin-4 encoding gene 
(ACTN4) and the myosin heavy chain 9 encoding gene (MYH9). The products of these 
genes are important to the structural and functional integrity of the podocytes and the slit 
diaphragm.  
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2 Objectives 
We investigated the pathomechanisms involved in the development of CKD and renal 
fibrosis using two different animal models of renal injury. 
 
In the diabetic nephropathy study we investigated early molecular changes in DN. The 
objectives were: 
1. To explore the changes in the protein expression profile of glomeruli at an early 
stage of the STZ-induced diabetes in rats. 
2. To identify glomerular proteins with altered expression compared to healthy 
controls. 
3. To identify the role of these proteins in the development of diabetic nephropathy. 
 
The toxic nephropathy study was based on an earlier study of our group. Rowett, black 
hooded (BH) rats were resistant to renal fibrosis induced by subtotal nephrectomy plus 
salt and protein loading. We conducted experiments to identify the possible mechanisms 
behind this resistance. Our previous study suggested that less oxidative stress may be 
responsible for the observed resistance of the Rowett rats to renal fibrosis. We used the 
Doxorubicin nephropathy model for our investigations. The objectives were: 
1. To investigate whether Rowett rats develop less severe renal injury than control 
CD rats in a model of chronic renal fibrosis initiated by toxic podocyte injury. 
2. To identify structural changes in the kidney of Rowett rats after direct toxic 
damage to podocytes. 
3. To analyze the possible pathogenic role of oxidative and nitrative stress in the 
kidney of Rowett rats after renal injury. 
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3 Methods 
3.1. Animals and experimental design 
We used male Sprague-Dawley (SD) rats  weighing 230 +/- 10 grams, 12 weeks old obese 
(fa/fa) and lean (fa/+) Zucker rats  in the diabetic nephropathy study. In the toxic 
nephropathy study, BH rats were compared to Charles Dawley (CD) rats at eight weeks of 
age. 
3.2. The diabetic nephropathy study 
3.2.1. Induction of diabetes 
Male SD rats were injected intraperitoneally with 60 mg/kg streptozotocin (STZ) 
dissolved in citrate buffer, pH 4.5. The control group received citrate buffer only 
(n=5/group). Development of diabetes was confirmed one week after streptozotocin 
injection by measuring post-prandial blood glucose. Oral glucose tolerance test was 
performed at sacrifice, four weeks after STZ injection. Urinary albumin excretion was 
measured before and 4 weeks after STZ injection when the experiment was terminated. 
12 weeks old obese (fa/fa) and lean (fa/+) Zucker rats were used to analyze the ezrin 
expression level in a different animal model of DN. The obese Zucker rats develop severe 
hyperphagia, obesity and type II DM-like characteristics spontaneously over time. 
 
3.2.2. Urinary albumin determination 
Urine was collected for 24 hours in diuresis cages before STZ injection for self-control 
purposes and 4 weeks later, before terminating the experiment. Urinary albumin was 
measured in the diabetic nephropathy study by a rat albumin-specific ELISA. 
 
3.2.3. Sacrifice and sample collection 
The STZ- or citrate-injected SD rats were anesthetized with ketamine + xylazine. Rats 
were bled from the aorto-iliac bifurcation, and were perfused through the aorta with 60 ml 
cold physiological saline. Both kidneys were removed for further analysis. One kidney 
from each animal was used for isolation of glomeruli by graded sieving.  
 
3.2.4. Two-dimensional fluorescence difference gel electrophoresis 
The isolated glomeruli from the diabetic or the control SD rats were lysed in protein 
isolation buffer. Protein concentrations were measured with 2D Quant Kit. 50 µg 
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glomerular lysate from rats with STZ-induced diabetes or controls were labeled 
individually with Cy3 and Cy5, respectively, using CyDye DIGE Fluor minimal labeling 
kit. An internal standard (a pool of all samples) was labeled with Cy2. Isoelectric focusing 
was performed using linear pH 3-10, 24 cm Immobiline™ DryStrips. Proteins were 
resolved in 12% polyacrylamide gels and imaged with Typhoon 9400. A comparison of 
the images was performed using DeCyder 2D 7.0 software. Reference gel was randomly 
selected from the control gels, and spots from the other gels were matched to those in the 
reference gel. The intensities of the spots were normalized by dividing each Cy3 or Cy5 
spot volume with the corresponding Cy2 (internal standard) spot volume. Normalized 
intensities of matched spots were compared between the groups, and spots with intensity 
changes >1.5-fold with a confidence interval (CI) above 95% (student’s t-test ANOVA 
analyses; p < 0.05) was considered differentially expressed and significant.  
 
3.2.5. Identification of proteins by LC-MS/MS 
Spots of interest were excised from a silver-stained 2D SDS-PAGE gel, in-gel digested 
with trypsin, and the resulting peptides were analyzed by liquid chromatography tandem 
mass spectrometry (LC-MS/MS). The LC-MS/MS data were searched with in-house 
Mascot through ProteinPilot 2.0 interface against the SwissProt database using the 
following criteria: rodent-specific taxonomy, trypsin digestion with one missed cleavage 
allowed, carbamidomethyl modification of cysteine as a fixed modification, and oxidation 
of methionine as a variable modification. All of the reported protein identifications were 
statistically significant (P < 0.05). 
 
3.2.6. Immunoblotting 
Glomerular lysates of three individual STZ-injected and three individual control rats were 
used for confirming the 2D-DIGE results. Glomerular lysates of 12 weeks old six 
individual obese (fa/fa) and six individual lean (fa/+) Zucker rats were used for analyzing 
the expression level of ezrin in type 2 diabetes. 
 
3.2.7. Immunohistochemistry of rat kidney samples 
Rat kidney cryosections from the STZ-, or citrate-injected SD rats were fixed with acetone 
and stained with mouse anti-ezrin, rabbit anti-phospho-ezrin rabbit anti-NHERF2 and 
rabbit anti-podocin. 
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3.2.8. Immunohistochemistry of human kidney samples 
Kidney samples of renal cancer patients with or without type 2 diabetes were obtained 
from surgical nephrectomies performed for diagnostic purposes at Helsinki and Uusimaa 
Hospital district, and were from the nonmalignant part of the kidney. Albuminuria, the 
clinical sign of diabetic nephropathy, was determined from the medical records. Tissue 
samples were stained for ezrin. Glomeruli (six/sample) were analyzed from 13 patients 
with type 2 diabetes and 14 controls. The staining intensity of ezrin was visually graded 
by two researchers independently and blinded from the diabetes status. For 
histopathological analysis the kidney samples were stained with PAS. 
 
3.3. The toxic nephropathy study 
3.3.1. Induction of toxic glomerular damage 
In the toxic nephropathy experimental series we performed the following two 
experiments: 
1. Renal functional and morphological experiment in DXR-induced renal failure; 
2. Long term survival study with low dose DXR; 
In the functional and morphological experiment (exp. 1) rats from both strains (n = 
8/group) were intravenously injected with 5 mg/kg body weight DXR dissolved in saline. 
The BH and CD rats in the negative control groups were injected with equal volume of 
saline only. Urinary protein and NGAL excretion was followed for 8 weeks when the 
experiment was terminated and renal morphology was investigated. 
Survival (exp. 2) was evaluated in age matched BH and CD rats (n = 8/group) (5 mg/kg 
DXR, iv). In the survival experiment animals were euthanized upon signs of uremia. 
In order to investigate whether the difference in the degree of tubulointerstitial fibrosis 
between the two rat strains was the consequence of different tubular protein load, or BH 
rats were resistant to tubulointerstitial fibrosis per se, we formed two sub-groups. In this 
analysis CD and BH rats injected with DXR (CD/DXRp, n = 4 and BH/DXRp, n = 5) 
were matched for urinary protein excretion and sensitive tubular, inflammatory and 
fibrosis parameters were compared. 
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3.3.2. Urinary protein and NGAL determinations 
In the renal functional and morphological experiment urine was collected for 24 hours in 
diuresis cages before and biweekly after DXR injection until the 8th week, when the 
experiment was terminated. In the toxic nephropathy study 24 hours total urine protein 
excretion was measured with a pyrogallol red colorimetric assay. Urine NGAL levels 
were measured with rat Lipocalin-2/NGAL DuoSet ELISA Development kit according to 
the manufacturer’s instructions. 
 
3.3.3. Sacrifice and sample collection 
When the experiments were terminated the rats were anesthetized, bled from the aorto-
iliac bifurcation and were perfused through the aorta. Both kidneys and the heart were 
removed. The heart and a third of the left kidney were embedded in paraffin for basic 
histological and immunohistochemical analysis. The remaining two thirds of the left 
kidney cortex and medulla were separated, frozen in liquid nitrogen and stored at -80°C 
for molecular studies. 
 
3.3.4. Renal morphology 
Kidney paraffin sections form the DXR-, or saline-injected rats were stained with 
hematoxylin-eosin (HE), periodic acid–Schiff (PAS), or Picro-Sirius Red. 
Glomerulosclerosis was assessed on PAS stained sections according to a modified scoring 
system (scores 0–4) of El Nahas et al. (magnification ×400). The glomerular score of each 
animal was derived as the arithmetic mean of 100 glomeruli. 
Tubulointerstitial damage was assessed on PAS stained sections with a semiquantitative 
scale (magnification ×100) of percent area affected by tubulointerstitial changes (scores 
0–4). The overall score was the mean of 15 fvs. 
Inflammatory infiltration was assessed on HE stained sections with a semiquantitative 
scale (magnification ×400) of percent area infiltrated by inflammatory cells (scores 0–4). 
The overall score was the mean of 120 fvs. 
Collagen deposition in the renal interstitium was demonstrated by Picro-Sirius Red 
staining, fibrotic areas were quantified using Image J software. 
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3.3.5. Immunoblotting 
Renal cortex samples from the DXR-, or saline-injected CD and BH rats were lysed in 
RIPA Buffer, protein concentration was determined by the bicinchoninic acid (BCA) 
protein assay. 20-20 μg protein were used form each rat to detect 4-hydroxy-2-nonenal 
(HNE) or to detect nitrotyrosine (NT). 
 
3.3.6. Immunohistochemistry of rat kidney samples 
Fibronectin immunohistochemistry was performed with anti-fibronectin antibody , using 
the avidin–biotin method. HNE and NT immunohistochemistry was performed with 
mouse monoclonal antibody. Color development was induced by incubation with 
diaminobenzidine (DAB) kit. 
 
3.3.7. Heart fibrosis markers 
In a separate group of DXR-injected BH and CD rats, the hearts were removed and 
embedded similarly to the renal samples 8 weeks after 5 mg/kg DXR administration. 
Consecutive sections were stained with Masson’s trichrome to detect collagen deposition 
as a sign of chronic fibrosis, and direct immunofluorescence was performed for connexin-
43 (Cx43), an early marker of cardiomyocyte damage. 
 
3.3.8. Monitoring mRNA levels with Real-Time quantitative Polymerase Chain Reaction 
(RT-qPCR) 
Total RNA for RT-qPCR was extracted by homogenizing 50-80 mg pieces of renal cortex 
in TRI. Reverse transcription of 1 μg total renal RNA into cDNA was carried out using 
random hexamer primers and the High-Capacity cDNA Archive Kit. Messenger RNA 
levels of NADPH oxidase-2 (NOX-2, p91phox, cytochrome b-245 beta polypeptide), 
neutrophil cytosolic factor 1 (Ncf1, p47phox), collagen type I, alpha 1 (COL1A1), 
transforming growth factor β1 (TGF-β1), connective tissue growth factor (CTGF) and 
macrophage chemotactic protein 1, (MCP-1, chemokine (C-C motif) ligand 2, Ccl2) were 
measured by RT-qPCR and target mRNA levels were normalized to actin mRNA levels. 
Nephrin mRNA levels were measured by double-stranded DNA (dsDNA) dye based RT-
qPCR with Maxima SYBR Green RT-qPCR Master Mix, and the mRNA values were 
normalized to glyceraldehyde-3-phosphate dehydrogenase. Mean values are expressed as 
fold mRNA levels relative to the control. 
9 
 
 
3.4. Statistics 
Unpaired t-test was used to evaluate the differences between the STZ-injected and the 
citrate-injected control SD rats, also to compare the variables of the two sub-groups within 
the BH/DXR and the CD/DXR groups. Two-way ANOVA with or without repeated 
measures were used for multiple comparisons. Post hoc analyses were done with Holm-
Sidak‘s test. Logarithmic transformation of data was used if Bartlett’s test indicated a 
significant inhomogeneity of variances. Survival was analyzed according to the Kaplan-
Meier method. The null hypothesis was rejected if p < 0.05. 
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4. Results 
4.1. Results of the diabetic nephropathy study 
4.1.1. Streptozotocin-induced diabetes leads to differential expression of glomerular 
proteins 
We compared total soluble protein fractions of glomeruli isolated from rats with 
streptozotocin-induced diabetes and controls using 2D-DIGE coupled with mass 
spectrometry 4 weeks after induction of diabetes. Analysis with DeCyder software 
revealed 2274 spots that were present in all five gels. Of the 2274 spots, 29 exhibited a 
statistically significant (Student’s t-test value ≤0.05) difference >1.5-fold between the 
diabetic and control rat glomerular samples. Fifteen spots were up-regulated (maximum, 
3.16-fold) and 14 were down-regulated (maximum, 3.11-fold) in the diabetic kidney 
glomeruli. Of the 29 differentially expressed spots, mass spectrometry identified multiple 
proteins in 17 spots, and a single protein in 12 spots, including actin binding and actin 
cytoskeleton organizing proteins, apoptosis-associated proteins, regulators of oxidative 
tolerance and DNA binding, and repair proteins. 
 
4.1.2. Ezrin and NHERF2 were down-regulated in the glomeruli of diabetic rats 
Ezrin and NHERF2 were both single identifications in the mass spectrometry, and showed 
2.1- and 1.94-fold decreases in diabetic glomeruli. Semiquantitative Western blot analysis 
confirmed that treatment with streptozotocin decreased the amount of ezrin by 49% and 
NHERF2 by 42% compared with citrate-injected rat glomeruli. Phosphorylation of ezrin 
at threonine 567 was reduced by 49%, indicating that both the total amount and the active 
ezrin are decreased in the glomeruli of rats with experimental diabetes. Also, podocalyxin, 
which is connected to actin through ezrin/NHERF2 complex, was down-regulated by 35% 
in the glomeruli of streptozotocin injected rats. The expression of podocin remained 
unchanged. Immunostaining revealed decreased expression of ezrin, NHERF2, and 
phosphorylated ezrin (p-ezrin) in the glomeruli of diabetic rats whereas podocin 
expression remained unchanged (Figure 1). 
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Figure 1: Immunofluorescence images of glomeruli of control (A-D) and streptozotocin-injected (E-H) rats 
stained for ezrin, NHERF2, phosphorylated ezrin (p-ezrin), and podocin. 
Ctrl: saline-injected, stz: Streptozotocin-injected rats. Scale bar = 30 µm. 
 
4.1.3. Expression of ezrin was reduced in glomeruli of obese Zucker rats and in glomeruli 
of patients with type 2 diabetes 
Semiquantitative Western blot analysis revealed that the expression of ezrin was 
decreased by 20% in glomeruli of obese Zucker rats when compared with that in lean 
Zucker rats. Immunohistochemistry (IHC) in human kidney samples obtained from 
nephrectomies showed significantly lower expression of ezrin in glomeruli of patients 
with diabetes. The patients did not have clinical nephropathy, and histopathological 
analysis revealed no diagnostic signs of diabetic nephropathy. 
 
4.2. Result of the toxic nephropathy study 
4.2.1. Heart toxicity was absent 8 weeks after injection with DXR at 5 mg/kg 
Histology of the heart did not show necrosis or other morphological alterations of 
cardiomyocytes. Massons’s trichrom staining was devoid of collagen deposition, and 
connexin-43 immunostaining did not demonstrate any sign of cardiomyocyte damage.  
 
4.2.2. CD rats became moribund earlier than BH rats 
BH rats became moribund significantly later following the 5 mg/kg DXR dose, compared 
to CD rats The mean survival after DXR was 85 days for the CD rats, while it was 108 
days for the BH rats (p<0.05). 
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4.2.3. DXR inhibited bodyweight gain more in CD than in BH rats 
Compared to strain identical controls, body weight gain was significantly inhibited in 
DXR-injected CD rats (CD/DXR) already starting at week 4. On the contrary, significant 
weight gain reduction was observed in BH rats (BH/DXR) only at week 8. 
 
4.2.4. Proteinuria was milder in BH than in CD rats after DXR-injection 
Treatment with 5 mg/kg DXR induced progressive proteinuria commencing 2 weeks after 
DXR in CD rats. Proteinuria started later and progressed slower and proteinuria was 
significantly milder at each time point in BH/DXR rats. Urinary NGAL a marker of distal 
tubular epithelial damage, increased in both DXR-injected groups after 4 weeks. Similarly 
to proteinuria, NGAL excretion was significantly milder in the BH/DXR group at all 
times. 
 
4.2.5. Renal histological damage and inflammation were more severe in CD than in BH 
rats 
The DXR-injected BH and CD rats developed FSGS-like lesions. Significantly more 
intact glomeruli (Score: 0) were found in DXR-injected BH rats (Table 1). Mild (Score: 
0.5–1.5) (CD: 50.7 vs. BH: 28.4%) and severe (Score ≤ 2) (CD: 13.3 vs. BH: 3.3%) 
glomerular damage was significantly more common in CD/DXR rats. In parallel with less 
proteinuria and morphological damage, inflammation was significantly milder in 
BH/DXR rats. 
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Table1: Renal morphology: score values 
CD: Charles Dawley rats, BH: Rowett, black hooded rats, /c: Saline-injected control rats, /DXR: Doxorubicin-
injected rats. (dose: 5 mg/kg). n=8/group 
Groups Intact 
glomeruli (%) 
Glomerulosclerosis 
score 
Tubular score Inflammation 
score 
CD/DXR 36.3 ± 13.4 0.79 ± 0.22 2.01 ± 0.64 1.61 ± 0.32 
BH/DXR 68.3 ± 8.4 0.32 ± 0.11 0.86 ± 0.44 1.06 ± 0.20 
Control 93.3 ± 4.4 0.06 ± 0.04 0.00 ± 0.00 0.18 ± 0.06 
P value 
(CD/DXR vs. 
BH/DXR) 
<0.001 <0.001 <0.001 <0.01 
 
4.2.6. Milder fibrosis was associated with less oxidative stress and inflammation in BH 
rats 
Fibrosis was strikingly more intense in CD/DXR than in BH/DXR rats as demonstrated by 
Sirius red staining. Fibronectin immunostaining was detected only in 5.2±0.6% of the 
scanned areas in the saline-injected control groups, but increased significantly in the 
DXR-injected CD group. Significantly less fibronectin staining was detected in BH/DXR. 
TGF-β1 and CTGF mRNA levels in the kidney cortex were not significantly different in 
the control groups compared to the DXR-injected BH rats, but were significantly elevated 
in the CD/DXR group. COL1A1 mRNA levels were elevated in the DXR-injected rats, 
but the elevation was significantly higher in the CD/DXR group. 
Nephrin mRNA levels decreased in the kidney cortex of the CD/DXR group, but it was 
not reduced in the BH/DXR group, supporting a milder glomerular damage. 
The mRNA levels of pro-inflammatory monocyte chemotactic protein 1 (MCP-1) and 
pro-oxidant markers: p91phox and p47phox increased in both DXR-injected groups; 
however the elevation was milder in the BH/DXR group. 
In the background of more severe kidney function deterioration demonstrated by 
proteinuria and fibrosis markers, severe lipid peroxidation and nitrative stress were 
detected in the kidneys of DXR-injected CD rats, while very mild changes were seen in 
the HNE or NT stained paraffin sections from the BH/DXR rats. Less staining was 
corroborated by Western blot demonstrating significantly more renal HNE and NT in CD 
rats 8 weeks after DXR administration. 
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4.2.7. Tubulointerstitial fibrosis and inflammation were milder in DXR-injected BH vs. 
CD rats despite similar proteinuria 
Urinary protein excretion and renal nephrin mRNA levels were similar in (BH/DXRp, and 
CD/DXRp rats with similar proteinuria. Markers of fibrosis were significantly lower in 
BH/DXRp rats. Paralleling less fibrosis and tubular damage, markers of oxidative damage 
were significantly lower in BH/DXRp rats (Table 2). 
 
Table 2: Comparison of doxorubicin-injected (DXR) Rowett, black hooded (BH) and Charles Dawley 
(CD) rats with similar proteinuria (BH/DXRp and CD/DXRp subgroups). 
 CD/DXRp (n = 4) BH/DXRp (n = 5) P value 
U Protein, week 8 (mg/24h) 396.5 ± 82.2 362.5 ± 30.3 0.42 
Nephrin 0.68 ± 0.16 0.87 ± 0.19 0.19 
U NGAL, week 8 (mg/24h) 10.1 ± 2.0 5.2 ± 1.6 <0.01 
Sirius red (%) 18.0 ± 1.6 11.8 ± 1.0 <0.01 
Fibronectin (%) 7.91 ± 2.45 5.55 ± 1.19 0.16 
TGF-β1 6.00 ± 2.36 2.13 ± 1.23 <0.05 
CTGF 3.71 ± 2.10 0.54 ± 0.11 <0.05 
COL1A1 23.09 ± 6.14 5.79 ± 2.41 <0.01 
p47phox 4.69 ± 1.51 1.95 ± 0.36 <0.05 
p91phox 10.69 ± 2.47 1.94 ± 0.78 <0.01 
MCP-1 9.23 ± 3.28 3.46 ± 0.99 <0.05 
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5. Conclusions 
Diabetic nephropathy (DN) is a serious complication of DM, and despite the extensive 
investigations of this disease, there are very few options for specific treatment. 
Fluorescence-based two-dimensional difference gel electrophoresis, coupled with mass 
spectrometry, identified 29 differentially expressed spots, including the actin-binding 
protein ezrin, and its interaction partner, NHERF2, which were down-regulated in 
streptozotocin-injected rats. Not just the total amount, but the active, phosphorylated ezrin 
was also reduced in diabetic rats. Podocalyxin is connected to actin through 
ezrin/NHERF2 complex, and it was down-regulated in STZ-induced diabetic rats. Ezrin 
expression was also lower in obese, diabetic Zucker rats and in human patients with 
diabetes. In conclusion, our data suggest that down-regulation of ezrin may associate with 
the development of the kidney complication in diabetes. 
 
In our toxic nephropathy study, BH rats were resistant to renal fibrosis compared to CD 
rats. Fibrosis sensitive CD rats developed progressive proteinuria after DXR injection, 
with significant loss of nephrin, and FSGS-like histological lesions. DXR-injected BH rats 
had similar nephrin mRNA levels to that in the control rats of the same strain, with milder 
proteinuria and less severe glomerular changes. Consequent proteinuria contributed to the 
development of interstitial fibrosis and tubular atrophy. BH rats had reduced urinary 
NGAL excretion, accompanied by milder signs of tubulointerstitial inflammation and 
fibrosis, with less severe lipid peroxidation and protein nitrosylation. Interestingly, 
markers of tubular atrophy, interstitial fibrosis, oxidative- and nitrative stress were milder 
in BH rats even with similar levels of proteinuria. BH rats also had prolonged survival. In 
conclusion, resistance of BH rats against renal fibrosis highlighted the role of 
inflammation induced oxidative/nitrative stress in chronic podocyte injury leading to 
glomerulosclerosis and consequent proteinuria in DXR nephropathy. 
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